Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Real-world survival trends in smoldering versus symptomatic multiple myeloma: A SEER analysis, 2012–2020

Manzer Ali, Bolivia Fernandes, Rajesh Thirumaran, Kirti Arora, Hanzala Jehangir, Aftab Ahmed, Mohammed AL-Jumayli, Daniel Rosas, Muhammad Awais Bin Abdul Malik, Kevin Bera, Jamal Abdul Nasir, Rameen Nadeem Nadeem

Blood (2025) 146 (Supplement 1): 8127.

https://doi.org/10.1182/blood-2025-8127

Published: 2025

Journal Articles

Early detection of emerging safety signals in GVHD prophylaxis agents using a 12-year faers “slope-watch” approach

Manzer Ali, Bolivia Fernandes, Rajesh Thirumaran, Hanzala Jehangir, Mohammed AL-Jumayli, Aftab Ahmed, Daniel Rosas, Muhammad Awais Bin Abdul Malik, Kirti Arora, Kevin Bera, Jamal Abdul Nasir, Arbaz Hassan

Blood (2025) 146 (Supplement 1): 7767.

https://doi.org/10.1182/blood-2025-7767

Published: 2025

Journal Articles

Early versus late onset hematologic immune‐related adverse events following immune checkpoint inhibition: Temporal patterns, clinical profiles, and risk stratification in faers reports (2014–2025)

Aftab Ahmed, Manzer Ali, Rajesh Thirumaran, Hanzala Jehangir, Mohammed AL-Jumayli, Kirti Arora, Kevin Bera, Daniel Rosas, Muhammad Awais Bin Abdul Malik, Bolivia Fernandes, Muhammad Umer Javaid, Muhammad Arham

Blood (2025) 146 (Supplement 1): 7659.

https://doi.org/10.1182/blood-2025-7659

Published: 2025

Journal Articles

Changing patterns and comparative outcomes of “watch-and-wait” versus immediate therapy in CLL: A propensity-weighted SEER analysis, 2000–2020

Manzer Ali, Kashish Magnani, Saad Rashid, Daniel Rosas, Muhammad Awais Bin Abdul Malik, Rajesh Thirumaran, Kevin Bera, Hanzala Jehangir, Mohammed AL-Jumayli, Aftab Ahmed, Kirti Arora, Bolivia Fernandes, Jamal Abdul Nasir

Blood (2025) 146 (Supplement 1): 8069.

https://doi.org/10.1182/blood-2025-8069

Published: 2025

Journal Articles

Early post-marketing safety signals of CRISPR-edited exagamglogene autotemcel (Casgevy) versus lentiviral betibeglogene autotemcel (Zynteglo): A faers disproportionality study, 2014–2025

Aftab Ahmed, Rajesh Thirumaran, Manzer Ali, Hanzala Jehangir, Daniel Rosas, Jaison Lawrence Alexander Santhi, Muhammad Awais Bin Abdul Malik, Kevin Bera, Mohammed AL-Jumayli, Kirti Arora, Bolivia Fernandes, Muhammad Umer Javaid, Muhammad Arham

Blood (2025) 146 (Supplement 1): 7838.

https://doi.org/10.1182/blood-2025-7838

Published: 2025

Journal Articles

Cardiovascular safety profile of CD20 × CD3 bispecific antibodies compared to immune-checkpoint inhibitors: A faers analysis, 2014–2025

Manzer Ali, Zayd Parekh, Rohan Mylavarapu, Saad Rashid, Daniel Rosas, Muhammad Awais Bin Abdul Malik, Hanzala Jehangir, Rajesh Thirumaran, Aftab Ahmed, Mohammed AL-Jumayli, Kirti Arora, Kevin Bera, Bolivia Fernandes

Blood (2025) 146 (Supplement 1): 7657.

https://doi.org/10.1182/blood-2025-7657

Published: 2025

Journal Articles

Comparative suicide risk in hematologic versus solid organ malignancies: A SEER-based competing-risks and cause-specific analysis of 7.4 million reports

Aftab Ahmed, Manzer Ali, Rajesh Thirumaran, Mohammed AL-Jumayli, Hanzala Jehangir, Kirti Arora, Kevin Bera, Daniel Rosas, Muhammad Awais Bin Abdul Malik, Bolivia Fernandes, Muhammad Umer Javaid

Blood (2025) 146 (Supplement 1): 8096.

https://doi.org/10.1182/blood-2025-8096

Published: 2025

Journal Articles

Evolving prognostic impact of B symptoms in non-Hodgkin lymphoma: A competing-risks analysis of SEER data, 2010–2019

Manzer Ali, Saad Rashid, Rajesh Thirumaran, Mohammed AL-Jumayli, Daniel Rosas, Muhammad Awais Bin Abdul Malik, Kevin Bera, Aftab Ahmed, Bolivia Fernandes, Hanzala Jehangir, Kirti Arora

Blood (2025) 146 (Supplement 1): 8047.

https://doi.org/10.1182/blood-2025-8047

Published: 2025

Journal Articles

Signal-rich and signal-poor: Divergent detection of early bacterial sepsis and latent viral complications after hematopoietic stem cell transplantation in the FDA adverse event reporting system

Manzer Ali, Bolivia Fernandes, Rajesh Thirumaran, Hanzala Jehangir, Kirti Arora, Kevin Bera, Daniel Rosas, Muhammad Awais Bin Abdul Malik, Aftab Ahmed, Mohammed AL-Jumayli, Jamal Abdul Nasir, Rameen Nadeem Nadeem

Blood (2025) 146 (Supplement 1): 2509.

https://doi.org/10.1182/blood-2025-2509

Published: 2025

Journal Articles

Age at diagnosis shapes stage and survival in diffuse large B-cell lymphoma: A 22-year, population-based study of 94,598 SEER patients

Aftab Ahmed, Rajesh Thirumaran, Manzer Ali, Hanzala Jehangir, Daniel Rosas, Muhammad Awais Bin Abdul Malik, Mohammed AL-Jumayli, Jaison Lawrence Alexander Santhi, Kevin Bera, Kirti Arora, Bolivia Fernandes, Muhammad Umer Javaid, Muhammad Arham

Blood (2025) 146 (Supplement 1): 3666.

https://doi.org/10.1182/blood-2025-3666

Published: 2025

Journal Articles

Bleed-versus-clot paradox under immune-checkpoint inhibition: A decade-long US faers analysis reveals divergent class-specific hemostatic phenotypes

Manzer Ali, Bolivia Fernandes, Kirti Arora, Rajesh Thirumaran, Hanzala Jehangir, Mohammed AL-Jumayli, Daniel Rosas, Muhammad Awais Bin Abdul Malik, Kevin Bera, Aftab Ahmed, Jamal Abdul Nasir, Arbaz Hassan

Blood (2025) 146 (Supplement 1): 1313.

https://doi.org/10.1182/blood-2025-1313

Published: 2025

Journal Articles

Immune checkpoint inhibitor–associated cytopenias: A decade of real-world signal detection from faers (2014–2025)

Manzer Ali, Kashish Magnani, Saad Rashid, Rajesh Thirumaran, Hanzala Jehangir, Daniel Rosas, Muhammad Awais Bin Abdul Malik, Kevin Bera, Aftab Ahmed, Kirti Arora, Bolivia Fernandes, Mohammed AL-Jumayli, Jamal Nasir

Blood (2025) 146 (Supplement 1): 6255.

https://doi.org/10.1182/blood-2025-6255

Published: 2025

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Real-world survival trends in smoldering versus symptomatic multiple myeloma: A SEER analysis, 2012–2020

Early detection of emerging safety signals in GVHD prophylaxis agents using a 12-year faers “slope-watch” approach

Early versus late onset hematologic immune‐related adverse events following immune checkpoint inhibition: Temporal patterns, clinical profiles, and risk stratification in faers reports (2014–2025)

Changing patterns and comparative outcomes of “watch-and-wait” versus immediate therapy in CLL: A propensity-weighted SEER analysis, 2000–2020

Early post-marketing safety signals of CRISPR-edited exagamglogene autotemcel (Casgevy) versus lentiviral betibeglogene autotemcel (Zynteglo): A faers disproportionality study, 2014–2025

Cardiovascular safety profile of CD20 × CD3 bispecific antibodies compared to immune-checkpoint inhibitors: A faers analysis, 2014–2025

Comparative suicide risk in hematologic versus solid organ malignancies: A SEER-based competing-risks and cause-specific analysis of 7.4 million reports

Evolving prognostic impact of B symptoms in non-Hodgkin lymphoma: A competing-risks analysis of SEER data, 2010–2019

Signal-rich and signal-poor: Divergent detection of early bacterial sepsis and latent viral complications after hematopoietic stem cell transplantation in the FDA adverse event reporting system

Age at diagnosis shapes stage and survival in diffuse large B-cell lymphoma: A 22-year, population-based study of 94,598 SEER patients

Bleed-versus-clot paradox under immune-checkpoint inhibition: A decade-long US faers analysis reveals divergent class-specific hemostatic phenotypes

Immune checkpoint inhibitor–associated cytopenias: A decade of real-world signal detection from faers (2014–2025)

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only